openPR Logo
Press release

Drug Integrated Polymer Fibers Market to witness significant demand in North America

05-21-2021 11:10 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: global market insights

Drug Integrated Polymer Fibers Market

Drug Integrated Polymer Fibers Market

According to the recent report by Global Market Insights, Inc., drug integrated polymer fibers market size is predicted to surpass USD 88 million by the end of 2025.

Drug integrated polymer fibers are produced from polydioxanone, polylactic acid, polyglycolic acid, polycaprolactone and their derivatives. These fibers are used for orthopedic sutures, drug delivery, dermal applications and grafts & stents. They are available for a medical textile device in knitted, braided or woven form. Medical textile fibers are generally nontoxic, biodegradable, non-carcinogenic, non-allergic. The development of new yarns and fibers have expanded the application spectrum of the medical textiles field.

Request for a sample copy of this report @

Increased investments in healthcare infrastructure, growing population, technological advancements in medical textile sector are some factors responsible for the rising demand for drug integrated polymer fibers.

Biologics and pharma loaded fibers provide excellent mechanical support, unlike conventional drug deliver mediums like nano particles and microspheres. In addition, these fibers can be used in multi-layer formation with every layer comprising a combination of a unique polymer and drug. Pharma and biologics loaded fibers also release drugs at a slower rate in comparison to fibers of similar geometric formations. Such a diverse application range has promoted the usage of these polymer fibers.

Substantial advancements in regenerative medicine and tissue engineering, innovations in biologics and pharmaceutical products have increased the demand for drug integrated polymer fibers. Many biomedical-related applications use customized polymer fibers for meeting specific biological requirements. Therefore, the production process of these fibers depends on the application for which they will be used. For commercial applications, these fibers are manufactured using the melt extrusion method. But this method has its own set of limitations and they are addressed using a wet extrusion method. It gives these fibers positional stability and makes them ready for implant procedures.

Speaking about applications, the drug integrated polymer fibers are largely used for orthopedics. Growing geriatric population is considered the primary contributing factor for the proliferation of the segment. Elderly patients are primarily diagnosed with cardiovascular disorders and osteoarthritis which has boosted the usage of these fibers. In addition, innovations in fiber-based wound healing systems have benefitted the patients undertaking orthopedic surgeries.

Request for customization @

Owing to the increased number of obesity and osteoporosis patients, the North America region subjugated the drug integrated polymer fibers market and is predicted to continue this trend in the coming years. Growing trend of 3D printing, advancements in robotics & smart implant technology and extensive research activities on nanotechnology have primarily contributed to the drug integrated polymer fibers market growth in the region. On the other hand, the Asia Pacific region has witnessed substantial market growth over the years. Developing nations like India, Thailand, China are potential hubs for bone grafting procedures in the future.

The only two players active in the drug integrated polymer fibers market are TissueGen Inc. and Micro Engineering Solutions. However, with the amount of potential that these fibers possess, it is highly likely that many companies will enter this market for developing products serving biomedical applications line vascular grafts, dermal wound healing, etc.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Toll Free: 1-888-689-0688

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Integrated Polymer Fibers Market to witness significant demand in North America here

News-ID: 2288026 • Views: 224

More Releases from global market insights

Acoustic Diaphragm Market slated to observe traction for polypropylene material …
With a seismic rise in the demand for consumer products such a loudspeakers, mobile phones and earphones, acoustic diaphragm market size is slated to surge in the next five years. Notably, acoustic diaphragm tends to inter-convert mechanical vibration to sounds and has become highly popular in headphones and speakers. Market penetration of materials such as paper, polycarbonate, polypropylene, carbon fiber and aluminum has become more pronounced in the past several
How will increasing demand for stainless steel transform the Ferroalloys Market …
One of the recent breakthroughs in the global ferroalloys market is the potential acquisition of Ferro Alloys Corporation by Vedanta- a natural resource company early this year. As per reliable sources, the acquisition is expected to complement Vedanta’s current steel business considering the fact that integration of Ferro manufacturing capabilities would offer the possibility to generate significant efficiencies. Meanwhile, yet other company, Boston Metal has declared having raised over USD 20
Polyphenylsulfone Market 2021 | Regional Insights & Growth Forecast To 2025
The polyphenylsulfone market will witness significant expansion with the rise in healthcare concerns and the growing requirement for biocompatible products. Polyphenylsulfone is a high-performance thermoplastic that is amorphous, heat-resistant, and transparent. It showcases high sterilization properties and is widely employed as an alternative for polyetheretheketone and polyaryletherketone. Furthermore, the polymer sees large adoption across various verticals of the healthcare sector to offer superior dimensional stability and higher resistance against
Cosmetic Contact Lens Market 2021: Industry Growth, Competitive Analysis, Future …
Increasing trend of using colored contact lenses may have a positive impact on cosmetic contact lens market outlook. Rising popularity of customized lenses with attractive colors, shades and textures for improving eye appearance is likely to propel industry size. Proliferation of entertainment, online and social media platforms are helping boost the adoption of such lenses. Cosmetic contact lenses are available in several colors such as blue, green, brown, hazel, grey, violet

All 5 Releases

More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample - Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning